Compare GSUN & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSUN | CCM |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0M | 23.8M |
| IPO Year | 2022 | 2009 |
| Metric | GSUN | CCM |
|---|---|---|
| Price | $1.56 | $3.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 212.4K | 3.4K |
| Earning Date | 02-12-2026 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $25,314,724.00 | ★ $51,056,841.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 526.22 | N/A |
| 52 Week Low | $1.25 | $3.54 |
| 52 Week High | $5.25 | $10.77 |
| Indicator | GSUN | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 42.45 |
| Support Level | $1.29 | $3.54 |
| Resistance Level | $1.58 | $4.00 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 72.09 | 59.21 |
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.